Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11841428 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: dexamethasone;   Drug: thalidomide;   Drug: zoledronic acid

Indicates status has not been verified in more than two years